Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PCNA | P12004 | 6/20 | 1.00 |
| ▸ | THRB | P10828 | 9/20 | 0.77 |
| ▸ | THRA | P10827 | 6/20 | 0.77 |
| ▸ | LMNA | P02545 | 4/20 | 0.77 |
| ▸ | MEN1 | O00255 | 4/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.77 |
| ▸ | PPARG | P37231 | 3/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.77 |
| ▸ | TSHR | P16473 | 1/20 | 0.77 |
| ▸ | GABRP | O00591 | 1/20 | 0.77 |
| ▸ | GABRD | O14764 | 1/20 | 0.77 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.77 |
| ▸ | F2 | P00734 | 1/20 | 0.77 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.77 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.77 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.77 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.77 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.77 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.77 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL428139 | 1.00 | PCNA (1.00) | PCNATHRBTHRALMNAMEN1 | |
| SCHEMBL1487713 | 1.00 | PCNA (1.00) | PCNATHRBTHRALMNAMEN1 | |
| Water SCHEMBL28780882 | 0.99 | PCNA (0.97) | PCNATHRBTHRALMNAMEN1 | |
| SCHEMBL4439595 | 0.99 | PCNA (0.97) | PCNATHRBTHRALMNAMEN1 | |
| Water SCHEMBL28780879 | 0.99 | PCNA (0.97) | PCNATHRBTHRALMNAMEN1 | |
| SCHEMBL11198581 | 0.92 | PCNA (0.86) | PCNATHRBTHRALMNAMEN1 | |
| SCHEMBL19048382 | 0.91 | PCNA (0.84) | PCNATHRBTHRALMNAMEN1 | |
| Azobenzene SCHEMBL11883178 | 0.91 | PCNA (0.82) | PCNATHRBTHRALMNAMEN1 | |
| Azobenzene SCHEMBL11883187 | 0.91 | PCNA (0.82) | PCNATHRBTHRALMNAMEN1 | |
| SCHEMBL5124875 | 0.90 | PCNA (0.81) | PCNATHRBTHRALMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1231 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4733383-A1 | CULTURE MEDIUM AND BLOOD CELL CLONE, AND METHOD FOR PRODUCING SAME | Japan Institute for Health Security (JP) | 2026-04-29 | — | — | EP | claimed |
| US-20260097100-A1 | CANCER TREATMENT BY INDUCTION OF TUMOR AND STEM CELL DIFFERENTIATION | LATHAM KEITH ROGER (US) | 2026-04-09 | — | — | US | claimed |
| EP-4688727-A1 | NOVEL L-THYROXINE RADIOIODINE LABEL AND PROCESS FOR PRODUCTION THEREOF | Forschungszentrum Jülich GmbH (DE) | 2026-02-11 | — | — | EP | claimed |
| EP-4684002-A2 | THYROCYTES AND USES THEREOF | Lifenet Health (US) | 2026-01-28 | — | — | EP | claimed |
| US-20250345488-A1 | CROSSLINKED HYDROGELS WITH ENHANCED RADIOPACITY FOR MEDICAL APPLICATIONS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-11-13 | — | — | US | claimed |
| CN-120121693-A | Identification of thyroid hormones using reactive heterogeneous nanopores | 南京大学 | 2025-06-10 | — | — | CN | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| WO-2024262610-A1 | CULTURE MEDIUM AND BLOOD CELL CLONE, AND METHOD FOR PRODUCING SAME | 国立研究開発法人国立国際医療研究センター | 2024-12-26 | — | — | WO | claimed |
| US-20240355474-A1 | METHODS FOR DETERMINING THE BENEFITS AND RISKS IN HEALTHCARE APPLICATIONS | MATT JR RICHARD GEORGE (US) | 2024-10-24 | — | — | US | claimed |
| EP-0467466-A1 | Method for the purification of immunoreactive labeled thyroxine conjugates | EASTMAN KODAK COMPANY (US) | 1992-01-22 | — | — | EP | claimed |
| US-4711855-A | Derivatives of 3,5,3-triiodothyronine | CIBA CORNING DIAGNOSTICS CORP. (US) | 1987-12-08 | — | — | US | claimed |
| EP-0073865-B1 | DERIVATIVES OF IODOTHYRONINE COMPOUNDS AND THEIR USE IN AN ASSAY FOR THE FREE IODOTHYRONINE COMPOUNDS | AMERSHAM INTERNATIONAL plc (GB) | 1986-01-29 | — | — | EP | claimed |
| EP-0093653-B1 | PROCESS FOR THE PREPARATION OF IODO-THYRONINES AND IODO-THYROACETIC ACIDS BY ELECTROCHEMICAL REDUCTION AT A CONTROLLED POTENTIAL | SPIRAL Société à responsabilité limitée dite : (FR) | 1985-07-10 | — | — | EP | claimed |
| US-4524223-A | CHROMATOGRAPHIC SEPARATION OF DIASTEREOMERIC ESTERS | UOP INC. (US) | 1985-06-18 | — | — | US | claimed |
| US-4490221-A | Process for preparing iodothyronines and iodothyroacetic acids by electrochemical reduction at controlled potential | SPIRAL SOCIETE A RESPONSABILITE LIMITEE DITE (FR) | 1984-12-25 | — | — | US | claimed |
| US-4426453-A | Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds | AMERSHAM INTERNATIONAL LIMITED (GB) | 1984-01-17 | — | — | US | claimed |
| US-4418225-A | ESTERIFICATION WITH AMINO ACIDS | UOP INC. (US) | 1983-11-29 | — | — | US | claimed |
| EP-0093653-A1 | Process for the preparation of iodo-thyronines and iodo-thyroacetic acids by electrochemical reduction at a controlled potential | SPIRAL Société à responsabilité limitée dite : (FR) | 1983-11-09 | — | — | EP | claimed |
| EP-0073865-A1 | Derivatives of iodothyronine compounds and their use in an assay for the free iodothyronine compounds | AMERSHAM INTERNATIONAL plc (GB) | 1983-03-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260097100-A1 | CANCER TREATMENT BY INDUCTION OF TUMOR AND STEM CELL DIFFERENTIATION | TPO, TSHR, THRB | PCNA 4188/4885THRB 3/4885THRA 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.